Wedbush Boosts Vera Therapeutics (NASDAQ:VERA) Price Target to $21.00
Vera Therapeutics (NASDAQ:VERA – Free Report) had its target price boosted by Wedbush from $16.00 to $21.00 in a report published on Friday morning, Benzinga reports. They currently have a neutral rating on the stock. VERA has been the subject of several other research reports. JPMorgan Chase & Co. dropped their price objective on shares […]
More Stories
Top Cryptocurrency Stocks To Watch Now – April 8th
Robinhood Markets, Bit Origin, and Bitdeer Technologies Group are the three Cryptocurrency stocks to watch today, according to MarketBeat’s stock...
Best Gold Stocks Worth Watching – April 8th
Robinhood Markets, Coca-Cola, and Freeport-McMoRan are the three Gold stocks to watch today, according to MarketBeat’s stock screener tool. Gold...
Arrowstreet Capital Limited Partnership Acquires 9,713 Shares of The Middleby Co. (NASDAQ:MIDD)
Arrowstreet Capital Limited Partnership increased its stake in shares of The Middleby Co. (NASDAQ:MIDD – Free Report) by 157.9% during...
Palomar (NASDAQ:PLMR) Upgraded at JPMorgan Chase & Co.
JPMorgan Chase & Co. upgraded shares of Palomar (NASDAQ:PLMR – Free Report) from a neutral rating to an overweight rating...
NVIDIA Co. (NASDAQ:NVDA) Shares Sold by Schrum Private Wealth Management LLC
Schrum Private Wealth Management LLC cut its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 56.3% in the fourth...
8,268 Shares in NVIDIA Co. (NASDAQ:NVDA) Bought by Aigen Investment Management LP
Aigen Investment Management LP acquired a new position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) in the 4th...